150 MG Anti-cancer Erlotinib Tablets IP

150 MG Erlotinib Tablets IP is a medication used to treat pancreas cancer at the metastatic stage. It belongs to the category of general medicines and the recommended dosage is 150 mg. The dosage guidelines should be followed as per the suggestion of the healthcare provider. The tablets have to be stored in a dry place. The physical form of the medication is tablets. This medication works by blocking the action of an abnormal protein that signals cancer cells to multiply. By doing this, it slows down the growth of cancer cells, thereby preventing the spread of the disease. It is important to note that this medication should only be taken under the supervision of a healthcare professional.

FAQs of 150 MG Erlotinib Tablets IP: